Inventor · disambiguated record
Mark Klinger
Also filed as: KLINGER MARK
13 granted patents·10 pending applications·92 citations·filing 2002–2024
89Inventor score
Files withADAPTIVE BIOTECHNOLOGIES CORP14SEQUENTA INC4LITTELFUSE INC2Nykode Therapeutics ASA1SEQUENTA LLC1
Top patents by PatentIndex Score
23 records- 0195US10428325B1Identification of antigen-specific B cell receptorsADAPTIVE BIOTECHNOLOGIES CORP·Filed 2017·Granted Oct 1, 2019·11 cites·30 claims
- 0295US10077478B2Determining paired immune receptor chains from frequency matched subunitsADAPTIVE BIOTECHNOLOGIES CORP·Filed 2013·Granted Sep 18, 2018·30 cites·9 claims
- 0395US10066265B2Determining antigen-specific t-cellsADAPTIVE BIOTECHNOLOGIES CORP·Filed 2014·Granted Sep 4, 2018·25 cites·11 claims
- 0491US9499865B2Detection and measurement of tissue-infiltrating lymphocytesADAPTIVE BIOTECHNOLOGIES CORP·Filed 2012·Granted Nov 22, 2016·10 cites·29 claims
- 0588US9365901B2Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemiaADAPTIVE BIOTECHNOLOGIES CORP·Filed 2013·Granted Jun 14, 2016·10 cites·17 claims
- 0684US11261490B2Determining antigen-specific T-cellsADAPTIVE BIOTECHNOLOGIES CORP·Filed 2018·Granted Mar 1, 2022·1 cites·16 claims
- 0778US12351872B2Determining antigen-specific T-cellsADAPTIVE BIOTECHNOLOGIES CORP·Filed 2022·Granted Jul 8, 2025·0 cites·19 claims
- 0869US10435745B2Determining antigen-specific T-cellsADAPTIVE BIOTECHNOLOGIES CORP·Filed 2017·Granted Oct 8, 2019·0 cites·8 claims
- 0966US11390921B2Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)ADAPTIVE BIOTECHNOLOGIES CORP·Filed 2018·Granted Jul 19, 2022·1 cites·10 claims
- 1065US2025074966A1Agents and methods for preventing or inhibiting adaptive immune responses associated with multiple sclerosisADAPTIVE BIOTECHNOLOGIES CORP·Filed 2024·Application pending·0 cites
- 1164US12266425B1T cell receptor sequences diagnostic for COVID-19 and related compositionsADAPTIVE BIOTECHNOLOGIES CORP·Filed 2021·Granted Apr 1, 2025·0 cites·12 claims
- 1257US2023042101A1Determining WT-1-Specific T Cells and WT-1 Specific T Cell Receptors (TCRS)ADAPTIVE BIOTECHNOLOGIES CORP·Filed 2022·Application pending·0 cites
- 1357US2025049910A1Immunogenic Constructs And Vaccines For Use In The Prophylactic And Therapeutic Treatment Of Diseases Caused By SARS-CoV-2Nykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1454US2016258025A1Predicting patient responsiveness to immune checkpoint inhibitorsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 1554US2016186260A1Cancer vaccination with antigen evolutionSEQUENTA LLC·Filed 2014·Application pending·0 cites
- 1652US2015247198A1Monitoring clonotypes of plasma cell proliferative disorders in peripheral bloodSEQUENTA INC·Filed 2013·Application pending·0 cites
- 1751US2023382979A1Anti-sars-cov-2 antigen antibodies and related compositions and methodsADAPTIVE BIOTECHNOLOGIES CORP·Filed 2021·Application pending·0 cites
- 1849US2014342360A1Method of measuring immune activationSEQUENTA INC·Filed 2012·Application pending·0 cites
- 1949US2015031553A1Method of measuring immune activationSEQUENTA INC·Filed 2012·Application pending·0 cites
- 2048US12263179B1Lyme disease-associated T cell receptor-related methodsADAPTIVE BIOTECHNOLOGIES CORP·Filed 2020·Granted Apr 1, 2025·0 cites·10 claims
- 2145US7592893B2Multiple conductor indicatorLITTELFUSE INC·Filed 2008·Granted Sep 22, 2009·0 cites·7 claims
- 2245US7405646B2Multiple conductor indicatorLITTELFUSE INC·Filed 2002·Granted Jul 29, 2008·4 cites·12 claims
- 2345US2015038346A1Monitoring immune responsiveness to cancer vaccinationSEQUENTA INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Klinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →